Metropolitan Life Insurance Company (MetLife)’s Pulse Biosciences PLSE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-988	Closed	-$8.61K	–	1572
2024 Q1	$8.61K	Hold	988	–	–	﹤0.01%	2181
2023 Q4	$12.1K	Buy	+988	New	+$6.84K	﹤0.01%	2117
2021 Q4	–	Sell	-3,991	Closed	-$86.2K	–	2817
2021 Q3	$86.2K	Buy	+3,991	New	+$85.9K	﹤0.01%	2606
2021 Q2	–	Sell	-4,644	Closed	-$110K	–	2836
2021 Q1	$110K	Hold	4,644	–	–	﹤0.01%	2385
2020 Q4	$111K	Buy	+4,644	New	+$73.9K	﹤0.01%	2307
2017 Q3	–	Sell	-6,760	Closed	-$233K	–	2511
2017 Q2	$233K	Buy	+6,760	New	+$186K	﹤0.01%	2240

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s PLSE Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Pulse Biosciences (PLSE) in Q2 2024, closing a stake of 988 shares — an estimated $8.61K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in PLSE in Q2 2017 and held it in 6 quarters. The position peaked at $233K in Q2 2017. 57 funds tracked by Wall St. Rank hold PLSE as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Pulse Biosciences position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 988 Pulse Biosciences shares in Q2 2024, an estimated $8.61K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Pulse Biosciences in Q2 2017 and held it in 6 quarters.
Metropolitan Life Insurance Company (MetLife)'s Pulse Biosciences position peaked at $233K in Q2 2017.
57 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.